Advances in Heart Valve Surgery

Journal of Interventional Cardiology

Volumn 16, Issue 6, 2003, Pages 535-541

  Aazami, Matthias ^a   Schäfers, Hans Joachim ^a  

^a SAARLAND UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AORTA VALVE; BIOCOMPATIBILITY; BIOPROSTHESIS; CLINICAL TRIAL; CONFERENCE PAPER; HEART VALVE SURGERY; HUMAN; PRIORITY JOURNAL; STANDARDIZATION; SURGICAL TECHNIQUE;

AORTIC VALVE; BIOCOMPATIBLE MATERIALS; CARDIAC SURGICAL PROCEDURES; HEART VALVE DISEASES; HEART VALVE PROSTHESIS; HEART VALVE PROSTHESIS IMPLANTATION; HUMANS; MITRAL VALVE; PROSTHESIS DESIGN;

EID: 10744232523     PISSN: 08964327     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1540-8183.2003.01053.x     Document Type: Conference Paper

References (72)

1. Block PC. Percutaneous mitral valve repair for mitral regurgitation. J Interven Cardiol 2003;16:93-96.
2. Omnasch JF, Schneider F, Falk V, et al. Minimally invasive approach for redo mitral valve surgery: A true benefit for the patient. J Card Surg 2002;17:14-19.
3. Alvarez L, Escudero C, Figuera D, et al. The Björk-Shiley valve prosthesis. Analysis of long-term evolution. J Thorac Cardiovasc Surg 1992;104:1249-1258.
4. Milano AD, Bortolotti U, Mazzucco A, et al. Performance of the Hancock porcine bioprosthesis following aortic valve replacement: Considerations based on a 15-year experience. Ann Thorac Surg 1998;46:216-222.
5. Stewart S, Cianciotta D, Hicks GL, et al. The Lillehei-Kaster aortic valve prosthesis. Long-term result in 237 patients with 1253 patients-years of follow-up. J Thorac Cardiovasc Surg 1998;95:1023-1030.
6. Baudet EM, Puel V, McBride JT, et al. Long-term results of valve replacement with St. Jude Medical prosthesis. J Thorac Cardiovasc Surg 1995;109:858-870.
7. Kopf GS, Hammond GL, Geha AS, et al. Long-term performance of the St. Jude Medical valve: Low incidence of thromboembolism with modest dose of warfarin. Circulation 1987;76 (3 Pt 2):III132-III136.
8. Kutschka I, Schonrock U, Richter M, et al. Complex heart surgery using a minimalized cardiopulmonary bypass system (cardiovention): First clinical results. Heart Surg Forum 2003;6(Suppl. 1):S15-16.
9. Corbi P, Rahmati M, Donal E, et al. Prospective comparison of minimally invasive and standard techniques for aortic valve replacement: Initial experience in the first hundred patients. J Card Surg 2003;18:133-139.
10. Grossi EA, LaPietra A, Ribakove GH, et al. Minimally invasive versus sternotomy approaches for mitral reconstruction: Comparison of intermediate-term results. J Thorac Cardiovasc Surg 2001;121:708-713.
11. Dogan S, Dzemali O, Wimmer-Greinecker G, et al. Minimally invasive versus conventional aortic valve replacement: A prospective randomized trial. J Heart Valve Dis 2003;12:76-80.
12. Bonacchi M, Prifti E, Giunti G, et al. Does ministerotomy improve postoperative outcome in aortic valve operation? A prospective randomized study. Ann Thorac Surg 2002;73:460-465.
13. Aris A, Camara ML, Montiel J, et al. Ministernotomy versus median sternotomy for aortic valve replacement: A prospective, randomized study. Ann Thorac Surg 1999;67:1583-1587.
14. Aris A, Camara ML, Casan P, et al. Pulmonary function following aortic valve replacement: A comparison between ministernotomy and median sternotomy. J Heart Valve Dis 1999;8:605-608.
15. Detter C, Deuse T, Boehm DH, et al. Midterm results and quality of life after minimally invasive vs. conventional aortic valve replacement. Thorac Cardiovasc Surg 2002;50:337-341.
16. Christiansen S, Stypmann J, Tjan TD, et al. Minimally-invasive versus conventional aortic valve replacement-perioperative course and mid-term results. Eur J Cardiothorac Surg 1999;16:647-652.
17. Gallomy AC, Grossi EA, Bizekis CS, et al. Evolving techniques for mitral valve reconstruction. Ann Surg 2002;236(3):288-293.
18. Morgan JA, Thornton BA, Hollingsworth KW, et al. Does robotic surgery make minimally invasive cardiac surgery too expensive? A hospital cost analysis of robotic and conventional techniques. Heart Surg Forum 2003;6:114.
19. Arom KV, Nicoloff DM, Kersten TE, et al. St.Jude Medical prosthesis: Valve-related deaths and complications. Ann Thorac Surg 1987;43(6):591-598.
20. Dellgren G, David TE, Raanani E, et al. Late hemodynamic and clinical outcomes of aortic valve replacement with Carpentier-Edwards Perimount pericardial prosthesis. J Thorac Cardiovasc Surg 2002;124:146-154.
21. Peterseim DS, Cen YY, Cheruvu S, et al. Long-term outcome after biologic versus mechanical aortic valve replacement in 841 patients. J Thorac Cardiovasc Surg 1999 May;117(5):890-897.
22. Pupello DF, Bessone LN, Hiro SP, et al. Bioprosthetic valve durability in the elderly: The second decade. J Card Surg 1991;6(4Suppl):575-579.
23. Miller DL, Moris JJ, Schaff HV, et al. Reoperation for aortic valve periprosthetic leakage: Identification of patients at risk and results of operation. J Heart Valve Dis 1995 Mar;4(2):160-165.
24. Bharat V, Das NK, Mohanty B, et al. Reduction of mechanical heart valve thrombosis through a clinical audit. J Heart Valve Dis 2003 May;12(3):362-369.
25. Khan S. Long-term outcomes with mechanical and tissue valves. J Heart Valve Dis 2002 Jan;11(Suppl 1):S8-14.
26. Takkenberg JJ, van Herwerden LA, Eijkemans MJ, et al. Evolution of allograft aortic valve replacement over 13 years: Results of 275 procedures. Eur J Cardiothorac Surg 2002;21:683-691.
27. O'Brien MF, Harrocks S, Stafford EG, et al. The homograft aortic valve: A 29-year, 99.3% follow up of 1,022 valve replacements. J Heart Valve Dis 2001;10:334-344.
28. Oury JH, Mackey SK, Duran CMG. Critical analysis of the Ross procedure: Do its problems justify wider application? Semin Thorac Cadriovasc Surg 1999;11(Suppl. 1):55-61.
29. Dellgren G, Feindel CM, Bos J, et al. Aortic valve replacement with the Toronto SPV: Long-term clinical and hemodynamic results. Eur J Cardiothorac Surg 2002;21:698-702.
30. Fries R, Wendler O, Schieffer H, et al. Comparative rest and exercise hemodynamics of 23-mm stentless versus 23-mm stented aortic bioprostheses. Ann Thorac Surg 2000;69:817-822.
31. Bach DS, Cartier PC, Kon ND, et al. Impact of implant technique following freestyle stentless aortic valve replacement. Ann Thorac Surg 2002;74:1107-1113.
32. Gulbins H, Anderson I, Kilian E, et al. Five years of experience with mitral valve homografts. Thorac Cardiovasc Surg 2002 Aug;50(4):223-229.
33. Timek TA, Lai DT, Tibayan FA, et al. Hemodynamic performance of an unstented xenograft mitral valve substitute. J Thorac Cardiovasc Surg 2002;124(3):541-552.
34. Middlemost SJ, Sussman MJ, Patel A, et al. The stentless quadrileaflet bovine pericardial mitral valve: Early clinical results. J Heart Valve Dis 1999;8(2):174-179.
35. Walther T, Walther C, Falk V, et al. Stentless mitral valve replacement using the Quattro valve. Semin Thorac Cardiovasc Surg 1999;11(4 Suppl. 1):186-190.
36. Goldstein S, Clarke DR, Walsh SP, et al. Transpecies heart valve transplant: Advanced studies of a bioengineered xenoautograft. Ann Thorac Surg 2000 Dec;70(6):1962-1969.
37. Cunanan CM, Cabiling CM, Dinh TT, et al. Tissue characterization and calcification potential of commercial bioprosthetic heart valves. Ann Thorac Surg 2001;71(Suppl. 5):417-421.
38. Giradot MN, Torrianni M, Giradot JMD. Effect of AOA on glutaraldehyde-fixed bioprosthetic heart valve cusps and walls: Binding and calcification studies. Int J Artif Organs 1994;17:76-82.
39. Chen W, Kim JD, Schoen FJ, et al. Effect of 2-amino oleic acid exposure conditions on the inhibition of calcification of glutaraldehyde cross-linked porcine aortic valves. J Biomed Mater Res 1994;28:1485-1495.
40. Ozaki S, Herijgers P, Verbeken E, et al. The influence of stenting on the behavior of amino-oleic acid-treated, glutaraldehyde-fixed porcine aortic valves in a sheep model. J Heart Valve Dis 2000;9:552-560.
41. Dahm M, Pruefer D, Krummenauer F, et al. In vitro effects of anticalcification treatment on the calcium uptake of bioprosthetic materials. J Heart Valve Dis 1998;7:336-339.
42. Quintero LJ, Lohre JM, Hernandez N, et al. Evaluation of in vivo models for studying calcification behavior of commercially available bovine pericardium. J Heart Valve Dis 1998;7:262-267.
43. Jamieson WR, Rosado LJ, Munro AI, et al. Carpentier-Edwards standard porcine bioprosthesis: Primary tissue failure (structural valve deterioration) by age groups. Ann Thorac Surg 1988;46:155-162.
44. Jamieson WRE, Janusz MT, Burr LH, et al. Carpentier-Edwards supraannular porcine bioprosthesis: Second generation prosthesis in aortic valve replacement. Ann Thorac Surg 2001;71(Suppl. 5):S224-227.
45. David TE, Ivanov J, Armstrong S, et al. Late results of heart valve replacement with the Hancock II bioprosthesis. J Thorac Cardiovasc Surg 2001;121:268-278.
46. Banbury MK, Cosgrove DM, White JA, et al. Age and valve size effect on the long-term durability of the Carpentier-Edwards aortic pericardial bioprosthesis. Ann Thorac Surg 2001;72:753-757.
47. Poirer NC, Pelletier LC, Pellerin M, et al. 15-year experience with the Carpentier-Edwards pericardial bioprosthesis. Ann Thorac Surg 1998;66:S57-61.
48. Carpentier A. Cardiac valve surgery - the "French correction." J Thorac Cardiovasc Surg 1983;86:323-337.
49. Gramaglia B, Imazio M, Checco L, et al. Mitral valve prolapse. Comparison between valvular repair and replacement in severe mitral regurgitation. J Cardiovasc Surg 1999;40:93-99.
50. Grossi EA, Galloway AC, Miller JS, et al. Valve repair versus replacement for mitral insufficiency: When is a mechanical valve still indicated? J Thorac Cardiovasc Surg 1998;115(2):389-394.
51. Gillinov AM, Cosgrove DM, Blackstone EH, et al. Durability of mitral valve repair for degenerative disease. J Thorac Cardiovasc Surg 1998;116(5):734-743.
52. David TE, Omram A, Armstrong S, et al. Long-term results of mitral valve repair for myxomatous disease with and without replacement with expanded polytetrafluoroethylene. J Thorac Cardiovasc Surg 1998;115(6):1279-1285.
53. Gillinov AM, Cosgrove DM, Lythe BW, et al. Reoperation for failure of mitral valve repair. J Thorac Cardiovasc Surg 1997;113(3):467-473.
54. Phillips MR, Daly RC, Schaff HV, et al. Repair of anterior leaflet mitral valve prolapse: Chordal replacement versus chordal shortening. Ann Thorac Surg 2000;69:25-29.
55. Duebener LF, Wendler O, Nikoloudakis N, et al. Mitral-valve repair without annuloplasty rings: Results after repair of anterior leaflet versus posterior-leaflet defects using poltetrafluoethylene sutures for chordal replacement. Eur J Cardiothorac Surg 2000;17(3):206-212.
56. Maisano F, Torracca L, Oppizzi M, et al. The Edge-to Edge technique : A simplified method to correct mitral insufficiency. Eur J Cardiothorac Surg 1998;13(3):240-245.
57. Gillinov AM, Cosgrove DM. Mitral valve repair for degenerative disease. J Heart Valve Dis 2002;11(Suppl. 1):S15-20.
58. Sternik L, Zehr KJ, Orszulak TA, et al. The advantage of repair of the mitral valve in acute endocarditis. J Heart Valve Dis 2002;11:91-97.
59. Cosgrove DM, Rosenkranz ER, Hendren WG, et al. Valvuloplasty for aortic insufficiency. J Thorac Cardiovasc Surg 1991;102:571-577.
60. David TA, Feidel CM. An aortic valve-sparing operation for patients with aortic incompetence and aneurysm of the ascending aorta. J Thorac Cardiovasc Surg 1992;103:617-622.
61. Sarsam MA, Yacoub M. Remodeling of the aortic valve annulus. J Thorac Cardiovasc Surg 1993;105:435-438.
62. Duran CM, Gometza B, Shahid, et al. Treated bovine and autologous pericardium for aortic valve reconstruction. Ann Thorac Surg 1998;66(6Suppl.):S166-169.
63. Schäfers H.-J., Fries R, Langer F, et al. Valve preserving replacement of the ascending aorta-remodeling vs. reimplantation. J Thorac Cardiovasc Surg 1998;116:990-996.
64. Grinda JM, Latremouille C, Berrebi AJ, et al. Aortic cusp extension valvuloplasty for rheumatic aortic valve disease: Midterm results. Ann Thorac Surg 2002;74:438-443.
65. Langer F, Graeter T, Nikoloudakis N, et al. Valve-preserving aortic replacement: Does the additional repair of leaflet prolapse adversely affect the results? J Thorac Cardiovasc Surg 2001;122:270-277.
66. Yacoub MH, Gehle P, Chandrasekaran V, et al. Late results of a valve-preserving operation in patients with aneurysms of the ascending aorta and root. J Thorac Cardiovasc Surg 2001;121:1080-1090.
67. De Oliviera NC, David TE, Ivanov J, et al. Results of surgery for aortic root aneurysm in patients with Marfan syndrome. J Thorac Cardiovasc Surg 2003;125:789-796.
68. Fraser CD Jr, Wang N, Mee RB, et al. Repair of insufficient bicuspid aortic valves. Ann Thorac Surg 1994;58:386-390.
69. Rahimtoola SH. Choice of prosthetic heart valve for adult patients. J Am Coll Cardiol 2003;41:893-904.
70. Bonow RO, Carabello B, de Lean AC Jr, et al. ACC/AHA Guidelines for the management of patients with valvular heart disease. J Am Coll Cardiol 1998;32:1486-1588.
71. Smolens IA, Pagani FD, Deeb GM, et al. Prophylactic mitral reconstruction for mitral regurgitation. Ann Thorac Surg 2001;72:1210-1216.
72. David TE, Ivanov J, Armstrong S, et al. Late outcomes of mitral valve repair for floppy valves: Implications for asymptomatic patients. J Thorac Cardiovasc Surg 2003;125:1143-1152.